These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 30205701)

  • 21. Albumin - bilirubin (ALBI) versus Child-Turcotte-Pugh (CTP) in prognosis of HCC after stereotactic body radiation therapy.
    Su TS; Yang HM; Zhou Y; Huang Y; Liang P; Cheng T; Chen L; Li LQ; Liang SX
    Radiat Oncol; 2019 Mar; 14(1):50. PubMed ID: 30917853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of Newly Proposed Time to Transarterial Chemoembolization Progression in Intermediate-Stage Hepatocellular Carcinoma Cases.
    Izumoto H; Hiraoka A; Ishimaru Y; Murakami T; Kitahata S; Ueki H; Aibiki T; Okudaira T; Miyamoto Y; Yamago H; Iwasaki R; Tomida H; Mori K; Kishida M; Tsubouchi E; Miyata H; Ninomiya T; Kawasaki H; Hirooka M; Matsuura B; Abe M; Hiasa Y; Michitaka K; Kudo M
    Oncology; 2017; 93 Suppl 1():120-126. PubMed ID: 29258105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of albumin-bilirubin grade versus Child-Pugh score in predicting the outcome of transarterial chemoembolization for hepatocellular carcinoma using time-dependent ROC.
    Zhao S; Zhang T; Li H; Wang M; Xu K; Zheng D; Du X; Liu L
    Ann Transl Med; 2020 Apr; 8(8):538. PubMed ID: 32411761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A New Prognostic Model Based on Albumin-Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan Criteria.
    Ho SY; Liu PH; Hsu CY; Hsia CY; Huang YH; Su CW; Lei HJ; Lee RC; Hou MC; Huo TI
    Dig Dis Sci; 2020 Feb; 65(2):658-667. PubMed ID: 31659612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Albumin-Bilirubin (ALBI) Grade-Based Nomogram for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
    Ho SY; Hsu CY; Liu PH; Lee RC; Ko CC; Huang YH; Su CW; Hou MC; Huo TI
    Dig Dis Sci; 2021 May; 66(5):1730-1738. PubMed ID: 32548811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of the albumin-bilirubin grade-based integrated model as a predictor for sorafenib-failed hepatocellular carcinoma.
    Lee PC; Chen YT; Chao Y; Huo TI; Li CP; Su CW; Lee MH; Hou MC; Lee FY; Lin HC; Huang YH
    Liver Int; 2018 Feb; 38(2):321-330. PubMed ID: 28736952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era.
    Liu PH; Hsu CY; Hsia CY; Lee YH; Chiou YY; Huang YH; Lee FY; Lin HC; Hou MC; Huo TI
    J Gastroenterol Hepatol; 2017 Apr; 32(4):879-886. PubMed ID: 27696519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of the Albumin-Bilirubin Grade in Predicting the Prognosis of Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    Xu L; Wu J; Lu W; Yang C; Liu H
    Transplant Proc; 2019 Dec; 51(10):3338-3346. PubMed ID: 31732203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysis.
    Mishra G; Majeed A; Dev A; Eslick GD; Pinato DJ; Izumoto H; Hiraoka A; Huo TI; Liu PH; Johnson PJ; Roberts SK
    J Gastrointest Cancer; 2023 Jun; 54(2):420-432. PubMed ID: 35635637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Albumin-Bilirubin Score: An Accurate Predictor of Hepatic Decompensation in High-Risk Patients Undergoing Transarterial Chemoembolization for Hepatocellular Carcinoma.
    Mohammed MAA; Khalaf MH; Liang T; Wang DS; Lungren MP; Rosenberg J; Kothary N
    J Vasc Interv Radiol; 2018 Nov; 29(11):1527-1534.e1. PubMed ID: 30274856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A nomogram to predict survival of patients with intermediate-stage hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.
    Ni JY; Fang ZT; Sun HL; An C; Huang ZM; Zhang TQ; Jiang XY; Chen YT; Xu LF; Huang JH
    Eur Radiol; 2020 Apr; 30(4):2377-2390. PubMed ID: 31900694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion.
    Waked I; Berhane S; Toyoda H; Chan SL; Stern N; Palmer D; Tada T; Yeo W; Mo F; Bettinger D; Kirstein MM; Iñarrairaegui M; Gomaa A; Vogel A; Meyer T; Sangro B; Lai P; Kumada T; Johnson PJ
    Br J Cancer; 2017 Feb; 116(4):448-454. PubMed ID: 28125820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver function assessment according to the Albumin-Bilirubin (ALBI) grade in sorafenib-treated patients with advanced hepatocellular carcinoma.
    Ogasawara S; Chiba T; Ooka Y; Suzuki E; Kanogawa N; Saito T; Motoyama T; Tawada A; Kanai F; Yokosuka O
    Invest New Drugs; 2015 Dec; 33(6):1257-62. PubMed ID: 26462681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transarterial Chemoembolization with Small Drug-Eluting Beads in Patients with Hepatocellular Carcinoma: Experience from a Cohort of 421 Patients at an Italian Center.
    Aliberti C; Carandina R; Lonardi S; Dadduzio V; Vitale A; Gringeri E; Zanus G; Cillo U
    J Vasc Interv Radiol; 2017 Nov; 28(11):1495-1502. PubMed ID: 28927662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-operative albumin-bilirubin grade predicts long-term outcomes among Child-Pugh grade A patients with hepatocellular carcinoma after curative resection.
    Amisaki M; Uchinaka E; Morimoto M; Tokuyasu N; Sakamoto T; Honjo S; Saito H; Fujiwara Y
    Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):502-509. PubMed ID: 30077606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma.
    Shao YY; Liu TH; Lee YH; Hsu CH; Cheng AL
    J Gastroenterol Hepatol; 2016 Jul; 31(7):1336-41. PubMed ID: 26860846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrograde portal vein flow and transarterial chemoembolization in patients with hepatocellular carcinoma - a case-control study.
    Kirstein MM; Voigtländer T; Schweitzer N; Gebel M; Hinrichs JB; Rodt T; Manns MP; Wacker F; Potthoff A; Vogel A
    Scand J Gastroenterol; 2017 Dec; 52(12):1398-1406. PubMed ID: 28847187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison Between Child-Turcotte-Pugh and Albumin-Bilirubin Scores in Assessing the Prognosis of Hepatocellular Carcinoma After Stereotactic Ablative Radiation Therapy.
    Lo CH; Liu MY; Lee MS; Yang JF; Jen YM; Lin CS; Chao HL; Shen PC; Huang WY
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):145-152. PubMed ID: 28816140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ASARA, a prediction model based on Child-Pugh class in hepatocellular carcinoma patients undergoing transarterial chemoembolization.
    Jia KF; Wang H; Yu CL; Yin WL; Zhang XD; Wang F; Sun C; Shen W
    Hepatobiliary Pancreat Dis Int; 2023 Oct; 22(5):490-497. PubMed ID: 35260337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade.
    Johnson PJ; Berhane S; Kagebayashi C; Satomura S; Teng M; Reeves HL; O'Beirne J; Fox R; Skowronska A; Palmer D; Yeo W; Mo F; Lai P; Iñarrairaegui M; Chan SL; Sangro B; Miksad R; Tada T; Kumada T; Toyoda H
    J Clin Oncol; 2015 Feb; 33(6):550-8. PubMed ID: 25512453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.